Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
Published in
Hepatology, vol. 51, no. 4, p. 1237-1243Publication date
2010Abstract
Keywords
- Adult
- Aged
- Carcinoma, Hepatocellular/mortality/ surgery
- Female
- Humans
- Immunosuppression
- Immunosuppressive Agents/ therapeutic use
- Liver Neoplasms/mortality/ surgery
- Liver Transplantation
- Male
- Middle Aged
- Sirolimus/ therapeutic use
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
TOSO, Christian et al. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. In: Hepatology, 2010, vol. 51, n° 4, p. 1237–1243. doi: 10.1002/hep.23437
Main files (1)
Article
Identifiers
- PID : unige:21345
- DOI : 10.1002/hep.23437
- PMID : 20187107
